跳至主要内容
临床试验/JPRN-UMIN000010213
JPRN-UMIN000010213已完成未知

Effect of coadministration of angiotensin II receptor blocker (ARB) and calcium channel blocker (CCB) on variability of home blood pressure in hypertensive outpatients - Effect of ARB/CCB combination on home blood pressure variability

Department of Nephrology and Hypertension, Kawasaki Medical School0 个研究点目标入组 300 人开始时间: 2013年4月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
300

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Patients with the past history of hypersensitivity to test drugs, other ARBs or dihydropyridine CCBs 2) Female in current or expected pregnancy 3) Patients with the past history of cerebro-cardiovascular diseases within six months 4) Patients whose blood pressures show more than 180/110mmHg 5) Patients receiving the dialysis therapy or with severe renal dysfunction (eGFR<30ml/min/1.73m2) 6) Patients with severe hepatic dysfunction (showing more than 100 IU/L of AST or ALT) 7) Patients receiving treatment for a malignant neoplasm 8) Patients taking a contraindication drug for coadministration of test drugs 9) Patients judged as unsuitable for participating in this study by the attending physician

研究者

发起方
Department of Nephrology and Hypertension, Kawasaki Medical School

相似试验